Università Vita-salute San Raffaele
Clinical trials sponsored by Università Vita-salute San Raffaele, explained in plain language.
-
Could a lung scarring drug help ARDS patients breathe easier?
Disease control Recruiting nowThis study tests whether pirfenidone, a drug already used for a different lung disease, can prevent scarring in patients with severe acute respiratory distress syndrome (ARDS). About 130 people on ventilators will receive either pirfenidone or a placebo through a feeding tube. Th…
Phase: PHASE3 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Heart drug during surgery may cut deadly complication risk
Disease control Recruiting nowThis study tests if adding the drug landiolol to the fluid that protects the heart during mitral valve surgery can reduce a serious complication called low cardiac output syndrome, where the heart struggles to pump enough blood after surgery. About 1500 adults having elective mit…
Phase: PHASE4 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a simple blood test catch pancreatic cancer before It's too late?
Diagnosis Recruiting nowThis study is testing a new blood test that looks at tiny particles called exosomes and their microRNA content, analyzed by machine learning, to detect pancreatic cancer early. It involves 600 people at high risk due to family history or pancreatic cysts. The goal is to see if th…
Sponsor: Università Vita-Salute San Raffaele • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Could a scan replace surgery for breast cancer staging?
Diagnosis Recruiting nowThis study tests whether a special PET/MRI scan can accurately detect if breast cancer has spread to lymph nodes in the armpit, potentially replacing the need for surgical removal of those nodes. About 119 women with certain types of breast cancer (luminal A or lobular) will get …
Phase: PHASE2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Ketamine booster for shock therapy? new trial aims to lift depression and protect memory
Symptom relief Recruiting nowThis phase 3 trial tests whether adding a low dose of ketamine to electroconvulsive therapy (ECT) can better relieve depression and reduce memory problems in people with treatment-resistant major depressive disorder. Thirty hospitalized adults will receive either ketamine or a pl…
Phase: PHASE3 • Sponsor: Università Vita-Salute San Raffaele • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New study aims to boost heart failure drug adherence
Knowledge-focused Recruiting nowThis observational study will track 300 adults with advanced heart failure to see how well they follow a four-medication treatment plan. Researchers will also measure quality of life using standard questionnaires. The goal is to understand real-world adherence and identify areas …
Sponsor: Università Vita-Salute San Raffaele • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Massive COVID-19 biobank aims to unlock secrets of severe disease
Knowledge-focused Recruiting nowThis study is collecting medical information and biological samples from up to 6,000 people with COVID-19. Researchers want to find out which factors predict severe illness, death, or response to treatment. The goal is to better understand the disease and help guide future care.
Sponsor: Università Vita-Salute San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Could a simple device let bystanders save lives in breathing emergencies?
Knowledge-focused Recruiting nowThis study tests a new portable CPAP device designed to help people with sudden breathing failure before they reach the hospital. Researchers want to see if the device is easy enough for non-medical people to use correctly. The study involves 50 participants: healthy older adults…
Phase: NA • Sponsor: Università Vita-Salute San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC